Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages.

导出 OA

翻译打印收藏纠错

第一作者： Mariko,Sakamoto

第一单位： Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

作者： Mariko,Sakamoto ^[1] ; Yoji,Murata ^[2] ; Daisuke,Tanaka ^[3] ; Yuka,Kakuchi ^[1] ; Takeshi,Okamoto ^[1] ; Daisuke,Hazama ^[1] ; Yasuyuki,Saito ^[1] ; Takenori,Kotani ^[1] ; Hiroshi,Ohnishi ^[1] ; Masayuki,Miyasaka ^[4] ; Masato,Fujisawa ^[5] ; Takashi,Matozaki ^[2]

作者单位： Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. ^[1] Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. ^[2] Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan; ymurata@med.kobe-u.ac.jp matozaki@med.kobe-u.ac.jp. ^[3] Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Gunma 371-8514, Japan. ^[4] Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan. ^[5]

关键词 SIRPα antibody cancer immunotherapy macrophage